Udenyca (Biosimilar to Neulasta) Now Approved Page




Brand: Udenyca (pegfilgrastim-cbqv), Injection
Parent Company: Coherus
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs
Patient Website: http://www.udenyca.com/
HCP Website: